Elmwood Wealth Management, Inc. Intellia Therapeutics, Inc. Transaction History

Elmwood Wealth Management, Inc.

$222 Million
Q3 2024

A detailed history of Elmwood Wealth Management, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Elmwood Wealth Management, Inc. holds 67,774 shares of NTLA stock, worth $816,676. This represents 0.63% of its overall portfolio holdings.

Number of Shares

67,774

Previous 67,174 0.89%

Holding current value

$816,676

Previous $1.5 Million 7.39%

% of portfolio

0.63%

Previous 0.73%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$19.72 - $27.36 $11,832 - $16,416	600 Added 0.89%	67,774 $1.39 Million
Q2 2024 Aug 13, 2024	SELL	$20.02 - $27.22 $14,514 - $19,734	-725 Reduced 1.07%	67,174 $1.5 Million
Q1 2024 May 10, 2024	SELL	$23.82 - $32.8 $238 - $328	-10 Reduced 0.01%	67,899 $1.87 Million
Q4 2023 Jan 30, 2024	BUY	$23.16 - $32.34 $231 - $323	10 Added 0.01%	67,909 $2.07 Million
Q2 2022 Jul 12, 2022	BUY	$38.49 - $76.21 $11,547 - $22,862	300 Added 0.44%	67,899 $3.51 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $24,764 - $50,570	425 Added 0.63%	67,599 $4.91 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $138,372 - $248,529	2,970 Added 4.63%	67,174 $5.39 Million
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $167,835 - $344,559	15,066 Added 30.66%	64,204 $1.35 Million
Q1 2020 May 12, 2020	SELL	$9.44 - $15.58 $142,223 - $234,728	-15,066 Reduced 23.47%	49,138 $600,000
Q4 2019 Feb 05, 2020	SELL	$10.43 - $17.67 $680,401 - $1.15 Million	-65,235 Reduced 50.4%	64,204 $942,000
Q3 2019 Nov 13, 2019	SELL	$13.07 - $18.51 $48,424 - $68,579	-3,705 Reduced 2.78%	129,439 $1.73 Million
Q2 2019 Aug 07, 2019	SELL	$13.88 - $18.41 $51,425 - $68,209	-3,705 Reduced 2.71%	133,144 $2.18 Million
Q1 2019 May 22, 2019	BUY	$12.79 - $17.62 $962,153 - $1.33 Million	75,227 Added 122.08%	136,849 $2.34 Million
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $42,199 - $100,516	-3,705 Reduced 5.67%	61,622 $841,000
Q3 2018 Oct 11, 2018	BUY	$25.78 - $32.6 $128,513 - $162,511	4,985 Added 8.26%	65,327 $1.87 Billion
Q2 2018 Aug 22, 2018	BUY	$20.02 - $30.79 $224,304 - $344,971	11,204 Added 22.8%	60,342 $1.65 Billion
Q1 2018 May 10, 2018	BUY	$19.43 - $34.95 $954,751 - $1.72 Million	49,138 New	49,138 $1.04 Billion

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.

Account

Elmwood Wealth Management, Inc. Intellia Therapeutics, Inc. Transaction History